Agilon Health Q1 EPS Beats Estimates, Raises Full-Year Revenue Guidance to $5.68–5.81B
AGL•Agilon Health reported Q1 net income of $48.9 million and adjusted EPS of $1.80, topping analysts’ estimate of $1.13 per share on revenue of $1.42 billion versus expectations of $1.38 billion. The company set full-year revenue guidance at $5.68–5.81 billion, while shares are up 62% year-to-date.
1. Q1 Financial Results
Agilon Health recorded net income of $48.9 million in Q1 2026, delivering adjusted earnings of $1.80 per share. Both figures exceeded analyst forecasts, demonstrating stronger-than-expected profitability in the period.
2. Revenue Performance
The company generated $1.42 billion in revenue for the quarter, surpassing the $1.38 billion consensus estimate by $40 million. This top-line outperformance reflects sustained demand across its senior-focused healthcare networks.
3. Guidance and Share Movement
Agilon raised its full-year revenue outlook to a range of $5.68 billion to $5.81 billion, signaling confidence in its growth trajectory. Shares have surged 62% year-to-date despite a 75% drop over the past 12 months, underscoring volatile market sentiment.
